MedTrace Logo

An AI-based mHealth Intervention to Improve HIV Testing

NCT05335096 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2026-01-28

No results posted yet for this study

Summary

The purpose of this study is to develop an artificial intelligence (AI)-chatbot-based mobile health (mHealth) intervention to promote HIV testing in Malaysia.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

An AI-chatbot-based mHealth intervention

The participants assigned to the intervention group will get access to an AI-chatbot and can interact with the AI-chatbot at any time. In each round of the interactive communication, the chatbot will provide automated personalized messages containing PrEP, mental health, or HIV testing-related information, motivation and skills based on the participants' answers and will continuously update over time.

BEHAVIORAL

An attention-chatbot-based mHealth intervention

The participants assigned to the control group will get access to an attention-chatbot and can interact with the attention-chatbot at any time. In each round of the interaction, the chatbot will provide pre-scripted time-attention health education messages to the participants.

BEHAVIORAL

Educational materials

the research assistant will manually sent to the participants' phone a piece of educational material and an online survey link every 30 days (at days 30, 60, 90, 120, 150 and 180).

Sponsors & Collaborators

  • University of Malaya

    collaborator OTHER

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Zhao Ni, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-26
Primary Completion
2026-03-15
Completion
2026-03-15

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05335096 on ClinicalTrials.gov